Overview

ABC008 in Subjects With T-cell Large Granular Lymphocytic Leukemia (T-LGLL)

Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
An open label, ascending dose study for adult subjects with T-cell Large Granular Lymphocytic Leukemia (T-LGLL)
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Abcuro, Inc.